Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial.

Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial. Nephrol Dial Transplant. 2018 04 01; 33(4):645-652.

View in: PubMed

subject areas

Adolescent
Adult
Age Factors
Antidiuretic Hormone Receptor Antagonists
Clinical Trials as Topic
Disease Progression
Female
Gene Rearrangement
Glomerular Filtration Rate
Humans
Hypertension
Kidney
Male
Middle Aged
Polycystic Kidney, Autosomal Dominant
Predictive Value of Tests
Prospective Studies
Research Design
Risk Assessment
Risk Factors
Severity of Illness Index
TRPP Cation Channels
Young Adult

authors with profiles

Arlene Chapman